X4 Pharmaceuticals Inc (NASDAQ:XFOR)

0.74
Delayed Data
As of Dec 01
 -0.04 / -5.13%
Today’s Change
0.65
Today|||52-Week Range
2.58
-25.48%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$122.7M

Company Description

X4 Pharmaceuticals, Inc. is a late clinical-stage company, which engages in the development and discovery of novel therapeutics for the treatment of rare diseases and those with limited treatment options. Its clinical candidate is mavorixafor. The company was founded by Henri A. Termeer, Keith T. Flaherty, Renato T. Skerlj, Richard Peters and Paula Ragan in 2010 and is headquartered in Boston, MA.

Contact Information

X4 Pharmaceuticals, Inc.
61 North Beacon Street
Boston Massachusetts 02134
P:(857) 529-8300
Investor Relations:

Employees

Shareholders

Other institutional31.29%
Mutual fund holders19.34%
Individual stakeholders1.56%

Top Executives

Paula S. RaganPresident, Chief Executive Officer & Director
Mary DiBiaseChief Operating Officer
Adam S. MostafaChief Financial Officer, Secretary & Treasurer
Art TaverasChief Scientific Officer
Christophe Arbet-EngelsChief Medical Officer